Dun Wang

730 total citations
35 papers, 544 citations indexed

About

Dun Wang is a scholar working on Biomedical Engineering, Molecular Biology and Oncology. According to data from OpenAlex, Dun Wang has authored 35 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Dun Wang's work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Dun Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Dun Wang collaborates with scholars based in China, United States and Japan. Dun Wang's co-authors include Yongjun Wang, Jingling Tang, Feng Liu, Xiaoguang Yang, Qiang Fu, Zhonggui He, Yuhua Wang, Zhenghong Xu, Haotian Zhang and Qiming Kan and has published in prestigious journals such as Chemical Engineering Journal, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Dun Wang

32 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dun Wang China 14 197 174 139 90 63 35 544
Marzena Szwed Poland 15 138 0.7× 267 1.5× 192 1.4× 145 1.6× 44 0.7× 41 643
Elizabeth Higbee‐Dempsey United States 12 173 0.9× 165 0.9× 132 0.9× 75 0.8× 45 0.7× 13 523
Vanminh Le China 14 159 0.8× 226 1.3× 112 0.8× 116 1.3× 55 0.9× 17 583
Guang Zhu China 14 137 0.7× 261 1.5× 92 0.7× 68 0.8× 21 0.3× 22 509
Xiaodan He China 11 181 0.9× 299 1.7× 180 1.3× 149 1.7× 20 0.3× 17 599
Xiaomeng Wan China 10 194 1.0× 194 1.1× 386 2.8× 93 1.0× 183 2.9× 14 700
Barbara Lettiero Sweden 11 124 0.6× 259 1.5× 206 1.5× 51 0.6× 24 0.4× 16 653
Shujun Shentu United States 11 212 1.1× 417 2.4× 141 1.0× 139 1.5× 39 0.6× 20 838
N. G. Yabbarov Russia 12 164 0.8× 156 0.9× 170 1.2× 59 0.7× 58 0.9× 56 515

Countries citing papers authored by Dun Wang

Since Specialization
Citations

This map shows the geographic impact of Dun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dun Wang more than expected).

Fields of papers citing papers by Dun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dun Wang. The network helps show where Dun Wang may publish in the future.

Co-authorship network of co-authors of Dun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dun Wang. A scholar is included among the top collaborators of Dun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dun Wang. Dun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenhao, Siqi Zhang, Xingkai Wang, et al.. (2025). Dual‐Targeting of PD‐L1 and Integrin αvβ3 for Preclinical PET Imaging of Cancer. ChemBioChem. 26(18). e202500508–e202500508. 1 indexed citations
2.
Qi, Qianqian, Zhanyu Zhang, & Dun Wang. (2025). GSH-responsive paclitaxel prodrug used in chemotherapy in combination with photodynamic therapy. Bioorganic Chemistry. 157. 108289–108289. 1 indexed citations
3.
Wang, Dun, et al.. (2024). Clinical features and surgical treatments of scoliosis in neurofibromatosis type 1: a systemic review and meta-analysis. European Spine Journal. 33(7). 2646–2665. 4 indexed citations
4.
Li, Jiwei, et al.. (2024). Structure-based approaches for the design of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d][1,2,3]triazoles as tubulin polymerization inhibitors. European Journal of Medicinal Chemistry. 269. 116309–116309. 3 indexed citations
5.
Ma, Qing, et al.. (2024). Histone lactylation in macrophage biology and disease: from plasticity regulation to therapeutic implications. EBioMedicine. 111. 105502–105502. 26 indexed citations
6.
Wang, Dun, et al.. (2023). Nf1 in heart development: a potential causative gene for congenital heart disease: a narrative review. Physiological Genomics. 55(10). 415–426.
7.
Wang, Zhichao, Dun Wang, Yuehua Li, et al.. (2023). Laser treatment for Cafe-au-lait Macules: a systematic review and meta-analysis. European journal of medical research. 28(1). 185–185. 2 indexed citations
8.
Wang, Xiaoyi, Ran An, Tao Wu, et al.. (2023). Evaluation of the effect of physical therapy on pain and dysfunction of knee osteoarthritis based on fNIRS: a randomized controlled trial protocol. BMC Musculoskeletal Disorders. 24(1). 3 indexed citations
9.
Wang, Kai‐Li, Yawen Zhang, Zhihong Bao, et al.. (2023). Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy. ACS Applied Materials & Interfaces. 15(14). 18191–18204. 26 indexed citations
10.
11.
Li, Jingbo, Xiaoguang Yang, Shuang Zhou, et al.. (2022). Doxorubicin-isoniazid conjugate regulates immune response and tumor microenvironment to enhance cancer therapy. International Journal of Pharmaceutics. 631. 122509–122509. 7 indexed citations
12.
13.
Wang, Dun, et al.. (2021). A systematic review and meta-analysis of the effect of preoperative exercise intervention on rehabilitation after total knee arthroplasty. Annals of Palliative Medicine. 10(10). 10986–10996. 20 indexed citations
14.
15.
Wang, Yan, Yanfeng Li, Jinbo Li, et al.. (2021). Doxorubicin-Near infrared dye conjugate induces immunogenic cell death to enhance cancer immunotherapy. International Journal of Pharmaceutics. 607. 121027–121027. 9 indexed citations
16.
Yang, Xiaoguang, et al.. (2019). Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity. Frontiers in Oncology. 9. 887–887. 26 indexed citations
17.
Wang, Dun, Yali Wang, Peng Zhang, et al.. (2019). New sesquiterpenoid derivatives from Ganoderma sinense with nitric oxide inhibitory activity. Phytochemistry Letters. 35. 84–87. 8 indexed citations
18.
Lv, Qingzhi, Xiaoguang Yang, Menglin Wang, et al.. (2018). Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye–monoamine oxidase A inhibitor conjugate. Journal of Controlled Release. 279. 234–242. 38 indexed citations
19.
Lv, Qingzhi, Dun Wang, Zimeng Yang, et al.. (2018). Repurposing antitubercular agent isoniazid for treatment of prostate cancer. Biomaterials Science. 7(1). 296–306. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marzena Szwed Breakdown of academic impact, for papers by Elizabeth Higbee‐Dempsey Breakdown of academic impact, for papers by Vanminh Le Breakdown of academic impact, for papers by Guang Zhu Breakdown of academic impact, for papers by Xiaodan He Breakdown of academic impact, for papers by Xiaomeng Wan Breakdown of academic impact, for papers by Barbara Lettiero Breakdown of academic impact, for papers by Shujun Shentu Breakdown of academic impact, for papers by N. G. Yabbarov
Rankless by CCL
2026